Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 6 January 2021, 17:48 HKT/SGT
Share:
    

Source: Hitachi, Ltd.
Olympus and Hitachi Announce Long-Term Business Alliance regarding Endoscopic Ultrasound Systems

TOKYO, Jan 6, 2021 - (JCN Newswire) - Olympus Corporation (TSE:7733) and Hitachi, Ltd. (TSE:6501) have signed a five-year contract to jointly develop Endoscopic Ultrasound Systems (EUS). Hitachi will also continue to supply diagnostic ultrasound systems and related parts used in EUS to Olympus under this contract.

EUS consist of a diagnostic ultrasound system and ultrasound flexible endoscopes. They are used in examinations to evaluate the stage of cancer in the liver, pancreas, and bronchus, as well as in minimally-invasive care, contributing to the medical treatment.

Hitachi's diagnostic imaging-related business is expected to be transferred to FUJIFILM Corporation, subject to customary closing conditions and regulatory approvals. The agreement between Hitachi and Olympus will be valid after such transfer.

Hironobu Kawano, Division Head of the Endoscopic Solutions Division, Olympus Corporation, said, "Olympus aims to improve patients' quality of life through early diagnosis made available with Endoscopic Ultrasound Systems. Our long-standing partnership with Hitachi has built a strong foundation of products and technology development for endoscopic ultrasound diagnosis, and we are very excited to be able to continue this collaboration and contribute further to improving patients' lives. Through this ongoing collaboration, Hitachi and Olympus will introduce products and technology that address the needs of the patients, healthcare professionals and the broader medical industry."

Toshihiko Kawano, CTO of Healthcare Business Unit, Hitachi, Ltd., said, "It is our pleasure to continue our collaboration with Olympus in the EUS business. Since the development of the first EUS product in the 1980s, Olympus and Hitachi have always been at the forefront in the market and have contributed significantly to progress the level and quality of treatment for digestive and respiratory diseases around the world. We look forward to collaborating in the future and exploring new clinical values to provide better diagnosis and treatment to patients and healthcare professionals, and contribute to the advancement of medical treatment."

About Olympus' Medical Business

Olympus' Medical business uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. Olympus' Medical portfolio includes endoscopes, laparoscopes, and video imaging systems, as well as surgical energy devices, system integration solutions, medical services, and a wide range of endotherapy instruments for endoscopic and therapeutic applications. For more information, visit www.olympus-global.com.

About Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, is focused on its Social Innovation Business that combines information technology (IT), operational technology (OT) and products. The company's consolidated revenues for fiscal year 2019 (ended March 31, 2020) totaled 8,767.2 billion yen ($80.4 billion), and it employed approximately 301,000 people worldwide. Hitachi drives digital innovation across five sectors - Mobility, Smart Life, Industry, Energy and IT - through Lumada, Hitachi's advanced digital solutions, services, and technologies for turning data into insights to drive digital innovation. Its purpose is to deliver solutions that increase social, environmental and economic value for its customers. For more information on Hitachi, please visit the company's website at https://www.hitachi.com.


Topic: Press release summary
Source: Hitachi, Ltd.

Sectors: MedTech
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2021 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


Hitachi, Ltd. Links

http://www.hitachi.com

https://www.facebook.com/hitachi.global/

https://twitter.com/hitachiglobal?lang=en

https://www.youtube.com/user/HitachiBrandChannel

https://ph.linkedin.com/company/hitachi

Hitachi, Ltd.
Apr 15, 2021 15:42 HKT/SGT
Local Production of Hitachi Automatic Analyzer 3500 to Commence in China
Apr 9, 2021 12:05 HKT/SGT
Hitachi Astemo to showcase advanced mobility solutions at Auto Shanghai 2021
Apr 7, 2021 14:32 HKT/SGT
Hitachi and Axcelead to start joint development of solutions for the efficient creation of next-generation biopharmaceuticals
Apr 1, 2021 12:11 HKT/SGT
Completion of Chubu Electric Power Grid Hida Converter Station Equipped with Hitachi's Frequency Converters
Mar 8, 2021 11:28 HKT/SGT
Hitachi Joins 'The Valuable 500', an International Initiative to Promote Disability Inclusion
Mar 3, 2021 10:48 HKT/SGT
Hitachi Developed the Hitachi Electronic Signature Service, to Eliminate Personal Seals with High Authenticity of Information by Blockchain Technology
Feb 1, 2021 16:22 HKT/SGT
Hitachi Launches 'Hitachi Industrial Edge Computer CE series Embedded AI model'
Jan 27, 2021 10:07 HKT/SGT
Hitachi Selected as a constituent of 'FTSE4Good Index Series' and 'FTSE Blossom Japan Index', World-leading ESG Indexes
Jan 12, 2021 11:21 HKT/SGT
Thailand's First Demonstration Project of Optimized Performance Enabling Network for Volt/Var(Q) (OPENVQ) in Power Transmission Networks
Jan 6, 2021 17:17 HKT/SGT
Hitachi Automotive Systems, Keihin, Showa, and Nissin Kogyo Conclude Management Integration and Commence Operations as Hitachi Astemo
More news >>
 News Alerts
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6859 8575

Connect With us: